Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Quantitative Medicine

Quantitative Medicine

Quantitative Medicine is a Pittsburgh-based computational biology company founded in 2012 by Robert Murphy, Joshua D. Kangas and Scott R. Bodine.

Quantitative Medicine is a computational biology company that developed data analytics software-as-a-service (SaaS) for drug development purposes. It was established in 2012 by Joshua D. Kangas, Robert Murphy, Scott R. Bodine. Quantitative Medicine was acquired by Predictive Oncology in January 2020. The company is headquartered in Pittsburgh, Pennsylvania, United States.

Products and Services

Quantitative Medicine's SaaS is called the Computational Research Engine (CoRE). It is used to accelerate drug development through the use of predictive analytics. The function is aimed at reducing testing intensity during the drug discovery and pre-clinical study phases. CoRE utilizes a database of existing therapeutical experiments in various drug development stages to generate testing results on the new drug compound based on the most similar conditions. However, Quantitative Medicine prefers that the software is used as a supporting mechanism to the crucial drug testing phases, instead of acting as their replacement.

Timeline

Patents

Further Resources

Title
Author
Link
Type
Date

Computational Research Engine (CoRE) Overview

Web

News

Title
Author
Date
Publisher
Description
BioSpace
June 17, 2021
BioSpace
MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, has announced the addition of Dr. Peter Bergethon, a world-leading expert in neurology, digital medicine, and central nervous system (CNS) drug development to the Company's Scientific Advisory Board.
Mind Medicine (MindMed) Inc.
June 17, 2021
www.prnewswire.com:443
/PRNewswire/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, has...

References

Golden logo
By using this site, you agree to our Terms & Conditions.